ClinicalTrials.gov
ClinicalTrials.gov Menu

Achieving Blood Pressure Control Through Enhanced Discharge (AchieveBP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02069015
Recruitment Status : Completed
First Posted : February 21, 2014
Last Update Posted : November 15, 2016
Sponsor:
Collaborator:
Blue Cross Blue Shield of Michigan Foundation
Information provided by (Responsible Party):
Julie Gleason-Comstock, Wayne State University

Brief Summary:
The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

Condition or disease Intervention/treatment Phase
Hypertension Behavioral: Patient education Not Applicable

Detailed Description:
A targeted sample of patients with uncontrolled blood pressure at the time of their emergency department visit discharge will be randomized into either standard or enhanced discharge. To control for medication effects in achieving blood pressure control, both groups will receive similar blood pressure medication while actively participating in the study.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Achieving Blood Pressure Control Through Enhanced Discharge
Study Start Date : October 2013
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2016

Arm Intervention/treatment
Experimental: Enhanced discharge
Patient education about hypertension delivered through a touch-screen kiosk at 4 time points in addition to standard discharge.
Behavioral: Patient education
Patient education on hypertension delivered through a touchscreen kiosk.

No Intervention: Standard discharge
Standard discharge is patient instruction, instructions for follow-up to primary care and medication/prescription



Primary Outcome Measures :
  1. Blood pressure control [ Time Frame: Baseline to ninety days ]
    Blood pressure readings of 140/90 for non-diabetic participants, and 130/80 for diabetic persons. Additionally, actual systolic and diastolic readings will be used as a continuous measure to determine if there is a significant change.


Secondary Outcome Measures :
  1. Patient activation measure (PAM) [ Time Frame: Baseline to 90 days ]
    Measure of how actively involved patient is in their medical care.


Other Outcome Measures:
  1. Emergency department visitation rate [ Time Frame: Baseline to 180 days ]
    Emergency department visits related to hypertension

  2. Patient centered cost effectiveness [ Time Frame: 180 days ]
    Patient willingness to pay

  3. Patient centered cost effectiveness [ Time Frame: 180 days ]
    Patient willingness to accept



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 89 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Present with uncontrolled blood pressure to the emergency department (>140/90 for non-diabetics and >130/80 for diabetics)
  • Self-reported history of hypertension

Exclusion Criteria:

  • End-stage renal disease
  • No history of hypertension
  • Do not present with uncontrolled blood pressure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02069015


Locations
United States, Michigan
Detroit Receiving Hospital Emergency Department
Detroit, Michigan, United States, 48201
Sponsors and Collaborators
Wayne State University
Blue Cross Blue Shield of Michigan Foundation
Investigators
Principal Investigator: Julie A Gleason-Comstock, PhD Wayne State University
Principal Investigator: Phillip D Levy, MD Wayne State University

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Julie Gleason-Comstock, Assistant Professor, Wayne State University
ClinicalTrials.gov Identifier: NCT02069015     History of Changes
Other Study ID Numbers: BCBSMF 1956.11
First Posted: February 21, 2014    Key Record Dates
Last Update Posted: November 15, 2016
Last Verified: November 2016

Keywords provided by Julie Gleason-Comstock, Wayne State University:
Patient education
Hypertension
Patient activation

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases